US Patent Issued to Signpath Pharma on Feb. 17 for "Dosing regimens for treatment of proliferative disorders" (New York Inventor)

ALEXANDRIA, Va., Feb. 17 -- United States Patent no. 12,551,436, issued on Feb. 17, was assigned to Signpath Pharma Inc. (Sandy, Utah).

"Dosing regimens for treatment of proliferative disorders" was invented by Peter Sordillo (New York).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention includes compositions and methods for treating a proliferative disorder comprising administering a therapeutically effective amount of an liposomal curcumin or curcuminoids to a human subject in need thereof in accordance with a dosing regimen comprising: at least one treatment cycle administering the therapeutically effective amount of the liposomal curcumin or curcuminoids once per week of at least 100 mg/m...